Free Republic 3rd Quarter Fundraising Target: $88,000 Receipts & Pledges to-date: $46,201
52%  
Woo hoo!! And we're now over 52%!! Thank you all very much!! God bless.

Keyword: pharmaceuticals

Brevity: Headers | « Text »
  • .@Merck Pharma is a leader in higher & higher drug prices while (....)taking jobs out of the U.S.

    08/14/2017 3:49:54 PM PDT · by SMGFan · 17 replies
    Real Donald Trump twitter account ^ | August 14, 2017 | President Donald Trump
    .@Merck Pharma is a leader in higher & higher drug prices while at the same time taking jobs out of the U.S. Bring jobs back & LOWER PRICES!
  • Merck CEO resigns from Trump council after Charlottesville

    08/14/2017 7:27:39 AM PDT · by SoFloFreeper · 54 replies
    Reuters ^ | 8/14/17
    Merck & Co Inc Chief Executive Kenneth Frazier resigned from U.S. President Donald Trump's American Manufacturing Council on Monday, saying he was taking a stand against intolerance and extremism.
  • Too Many Meds? America's Love Affair With Prescription Medication

    08/12/2017 8:00:25 PM PDT · by nickcarraway · 39 replies
    Consumer Reports ^ | August 03, 2017 | Teresa Carr
    We now take more pills than ever. Is that doing more harm than good? If you’re like most Americans, you probably start your day with a hot shower, a cup of coffee—and a handful of pills. More than half of us now regularly take a prescription medication—four, on average—according to a new nationally representative Consumer Reports survey of 1,947 adults. Many in that group also take over-the-counter drugs as well as vitamins and other dietary supplements. It turns out Americans take more pills today than at any other time in recent history (see “Pill Nation: The Rise of Rx Drug...
  • 'Pharma Bro' Shkreli is convicted at securities fraud trial

    08/04/2017 12:22:07 PM PDT · by NohSpinZone · 8 replies
    Fox Business News ^ | 8/4/17 | Tom Hays
    Martin Shkreli, the eccentric former pharmaceutical CEO notorious for a price-gouging scandal and for his snide "Pharma Bro" persona on social media, was convicted Friday on federal charges he deceived investors in a pair of failed hedge funds.
  • AmbioPharm Invests in $18M Expansion (100 jobs in South Carolina)

    07/21/2017 8:50:11 PM PDT · by 2ndDivisionVet · 1 replies
    Commercial Property Executive ^ | July 21, 2017 | Laura Calugar
    AmbioPharm Inc., a peptide and biopharmaceutical manufacturing company in North Augusta, S.C., plans to expand its existing Aiken County operations. The extension is projected to bring $18 million of new capital investment and lead to the creation of 100 jobs over the next five years. Located at 1024 Dittman Court, AmbioPharm is near Interstate 520. The company will start constructing two additional freestanding buildings, totaling 50,000 square feet, and purchasing additional equipment. The Coordinating Council for Economic Development approved job development credits related to this project. Third SC expansion AmbioPharm started its business in South Carolina 10 years ago by...
  • NPR Talks Smack

    06/30/2017 3:16:13 PM PDT · by yoe · 9 replies
    The Weekly Standard ^ | June 26, 2017 | By The Scrapbook
    Public radio doesn't quite know what it wants us to think about the anti-addiction medicine Vivitrol. At the beginning of the month Marketplace was touting Vivitrol as the "drug that heroin-proofs your brain," a sort of magic bullet for shooting the old monkey off one's back. The drug is essential, we were told, in keeping junkies out of jail. An addiction specialist raved that Vivitrol acts like "a kind of a force field around the part of your brain that likes heroin." The medicine is regularly given to inmates upon release from prison, so they can stay clean: It works...
  • Granules India Expansion Will Create More Than 100 Jobs In Virginia

    05/23/2017 3:08:11 PM PDT · by 2ndDivisionVet · 3 replies
    Business Facilities ^ | May 23, 2017
    Granules India Ltd. will invest $35 million into its subsidiary, Granules Pharmaceuticals Inc., to expand its pharmaceutical R&D and manufacturing capabilities in Fairfax County, VA. Before choosing Virginia, the company also considered New Jersey for the project, which will create 102 new jobs. In 2014, the company invested $15 million to establish its wholly-owned subsidiary operation, creating 75 jobs in Fairfax. India-based Granules India Ltd. manufactures Active Pharmaceutical Ingredients (APIs), Pharmaceutical Formulation Intermediates (PFIs), and Finished Dosages (FDs), distributed to customers in both regulated and semi-regulated markets. “Setting up a development and manufacturing presence in the United States was the...
  • State: Pharmaceutical Company To Create 361 Jobs In Windsor (Connecticut)

    05/09/2017 2:53:59 PM PDT · by 2ndDivisionVet · 2 replies
    WTIC-AM ^ | May 9, 2017
    WINDSOR, Conn. (CBS Connecticut) – An Arkansas-based pharmaceutical company plans to open a 90,000 square-foot manufacturing facility in Windsor, said the office of Governor Dannel Malloy Tuesday. SCA Pharmaceuticals plans to create 361 jobs at the facility over the next four years, said officials. SCA manufactures injectable pharmaceuticals in ready-to-administer dosages for use at hospitals and healthcare facilities. The company helps healthcare facilities increase efficiencies and reduce costs while improving patient care. SCA is leasing a facility at 755 Rainbow Road in Windsor. The state, through the Department of Economic and Community Development , will support the project with an...
  • How Trump Could Make Your Drugs Cheaper ... If He Dares

    04/24/2017 2:52:04 PM PDT · by 2ndDivisionVet · 13 replies
    OZY ^ | April 21, 2017 | Daniel Malloy, The Daily Dose
    For the more than 3 million Americans infected with potentially deadly hepatitis C, a relatively new cocktail of drugs is considered a miracle cure. The problem: Gilead Sciences’ list price is $84,000 for a 12-week treatment. From Martin Shkreli’s Turing Pharmaceuticals jacking up the AIDS drug Daraprim from $13.50 per pill to $750 in a single day to Mylan’s allergy-fighting EpiPens rising from $100 to $600 in just a few years, Americans are getting sick of astonishing drug prices. It’s why Donald Trump and Bernie Sanders both used their presidential campaigns to roast Big Pharma. In a primary-season rally in...
  • Pharmaceutical Giants Caught Supplying Cartels With Tons of Bulk Ingredients to Produce Meth

    04/17/2017 10:45:52 AM PDT · by LTC.Ret · 144 replies
    Quote the article: "Prosecutors in Belgium have recently announced that executives with pharmaceutical companies based in the country will be charged with knowingly providing drug cartels with prescription drugs that were used to manufacture methamphetamine. . . . accused of providing the Mexican drug kingpin Ezio Figueroa Vazquez with several tons of ephedrine . . . seven executives who were charged with crimes . . . company made two shipments of two million pills containing pseudoephedrine in 2006 . . . big pharma drug Adderall is nearly identical to crystal meth . . .the only place to get massive quantities...
  • Amgen chief tells Trump the biotech giant will hire 1,600 workers

    02/03/2017 6:46:59 PM PST · by 2ndDivisionVet
    The Los Angeles Times ^ | February 1, 2017 | Melody Petersen
    Amgen Chief Executive Robert Bradway told President Trump on Tuesday that the company would soon be adding 1,600 jobs. The news of hiring by the Southern California biotech giant came as the president met with a group of pharmaceutical executives at the White House, where he told them their pricing “has been astronomical.” “You folks have done a very great job over the years,” Trump told the executives, “but we have to get the prices down.” Kristen Davis, an Amgen spokeswoman, confirmed that the Thousand Oaks company plans to hire 1,600 skilled workers across the U.S. this year....
  • Trump tells drug-company execs to drop prices, promises to cut regulations

    01/31/2017 10:29:16 AM PST · by ColdOne · 20 replies
    washingtontimes.com ^ | 1/31/17 | Dave Boyer
    President Trump told pharmaceutical executives Tuesday he wants lower drug prices, and he pledged that the government will speed up approval times for new medicines. “You folks have done a terrific job over the years, but we have to get prices down for a lot of reasons,” Mr. Trump said at the White House. “We have no choice. For Medicare, for Medicaid, we have to get the prices way down.” The president urged the executives around a conference table to bring back their manufacturing operations to the United States, promising to cut regulations and speed up the Food and Drug...
  • Will Trump Appoint a Great FDA Commissioner?

    01/23/2017 7:33:30 AM PST · by reaganaut1 · 4 replies
    Marginal Revolution ^ | January 23, 2017 | Alex Tabarrok
    As someone who has written about FDA reform for many years it’s gratifying that all of the people whose names have been floated for FDA Commissioner would be excellent, including Balaji Srinivasan, Jim O’Neill, Joseph Gulfo, and Scott Gottlieb. Each of these candidates understands two important facts about the FDA. First, that there is fundamental tradeoff–longer and larger clinical trials mean that the drugs that are approved are safer but at the price of increased drug lag and drug loss. Unsafe drugs create concrete deaths and palpable fear but drug lag and drug loss fill invisible graveyards. We need an...
  • Trump team touts $8 billion Bayer investment

    01/17/2017 9:39:09 AM PST · by C19fan · 23 replies
    The Hill ^ | January 17, 2017 | Ben Kasmir
    German-based Bayer AG has committed to President-elect Donald Trump that it will invest $8 billion in American research and development as part of its deal to acquire Monsanto, Trump's transition team said Tuesday. Incoming White House press secretary Sean Spicer told reporters that Bayer will also protect all of Monsanto's 9,000 American jobs while creating an additional 3,000 high-tech positions in the country. That agreement, he added, came after Trump met with CEOs from both companies last week.
  • OcyContin's global drive: 'We're only just getting started

    12/27/2016 7:44:49 AM PST · by Mariner · 118 replies
    The Los Angeles Times via Sacramento Bee ^ | December 26th, 2016 | By HARRIET RYAN, LISA GIRION AND SCOTT GLOVER
    OxyContin is a dying business in America. With the nation in the grip of an opioid epidemic that has claimed more than 200,000 lives, the U.S. medical establishment is turning away from painkillers. Top health officials are discouraging primary-care doctors from prescribing them for chronic pain, saying there is no proof that they work long-term and substantial evidence that they put patients at risk. Prescriptions for OxyContin have fallen nearly 40 percent since 2010, meaning billions of dollars in lost revenue for its Connecticut manufacturer, Purdue Pharma. So the company's owners, the Sackler family, adopted a new strategy: Put the...
  • Dr. Manny: Trump's power of negotiation will save lives in the future

    12/07/2016 12:11:48 PM PST · by 2ndDivisionVet · 10 replies
    Fox News ^ | December 7, 2016 | Dr. Manny Alvarez
    I believe that President-elect Donald Trump will succeed in bringing down health care costs, and tackling soaring drug prices will be at the forefront of his battle. This may have come as a shock to the industry, who likely believed that they’d be given a free pass under a Republican presidency and Republican-controlled Congress. It is likely that on Election Day the Big Pharma companies prematurely let out a collective sigh of relief believing that a Republican-led government would never allow for imported medicines or for Medicare to negotiate drug prices, but it appears that the well-deserved panic is starting...
  • Eli Lilly Alzheimer’s Drug Fails Trial

    11/23/2016 7:27:10 AM PST · by RummyChick · 45 replies
    WSJ ^ | 11/23 | loftus
    An experimental Eli Lilly & Co. drug failed to significantly help Alzheimer’s disease patients in a closely watched clinical trial, dealing another blow to the pharmaceutical industry’s long quest to find a better treatment for the condition. The disappointing outcome also may revive doubts about an entire branch of Alzheimer’s research that has dominated the industry’s efforts in the past decade. Lilly and other companies have developed drugs that try to stop the buildup of a sticky protein in the brain known as beta amyloid—believed by many to be the primary culprit in the disease. But none of these drugs...
  • Hillary Clinton - Why She Can't Think [Dr. Ted Noel]

    11/01/2016 6:48:33 PM PDT · by Meet the New Boss · 21 replies
    Webtech Vidzette ^ | 31 Oct 2016 | Dr. Ted Noel
    In a new posting, Dr. Ted Noel: - points to recent evidence of Hillary Clinton symptoms of Parkinson's disease and its treatment, such as eye dyskinesia and gait - explains the difficulty of managing her condition with dosing of Levodopa, as to the daily cycle of effectiveness of the drug and side effects and - discusses the cognitive problems of people with this condition under this medication and why this is very important for a president, specifically the daily timing of "off states"
  • Ebola Czar Vanishes from Democracy Alliance Website Ron Klain no longer listed as a trustee

    10/20/2014 3:08:29 PM PDT · by Nachum · 23 replies
    Free Beacon ^ | 10/20/14
    Third Way, a progressive think tank with ties to the Democracy Alliance, has removed newly appointed Ebola czar Ron Klain from its website, following a Washington Free Beacon report. The Free Beacon reported Friday on Klain’s status as a trustee for Third Way, and his past experience lobbying on behalf of a drug company that was accused of denying life-saving drugs to dying cancer patients. The choice of Klain to head the administration’s emergency response to Ebola was criticized as a political move. Klain is a political operative with no medical experience and a former advisor to former Vice President...
  • DSN reader polls show narrow preference for Trump (Drug Store Industry)

    10/07/2016 12:32:24 PM PDT · by 2ndDivisionVet · 3 replies
    Drug Store News ^ | October 7, 2016
    As Election Day draws near, it looks like a slim majority of Drug Store News readers would prefer to see Donald Trump in the White House, according to our most recent online reader poll. Though the candidates are separated by fewer than 100 votes, at press time, 51% of readers (1163 votes) said they would vote Trump if the election were tomorrow, whereas 49% (1101 votes) said Hillary Clinton was their pick. These are the most recent results, but Drug Store News has been asking readers all year for their opinions on which candidate’s policies they would favor. We began...